RAPPORTEUR (EURACTIV) - Patients with rare neurological diseases wait around five years for a diagnosis, by which time their condition may have deteriorated, says Marullo di Condojanni. Unmet need in the field exceeds 90 per cent, but the problem, he argues, lies less in the science than in the system around it. Read more

An editorial studio for health and life sciences in Europe


nexxahealth
Europe's health & life sciences magazine
Europe's health & life sciences magazine launching on 12 October 2026. Four issues a year, in print. For innovators, health systems, policymakers, healthcare professionals, investors, patient organisations, and more.
Issue 01 - Counting on Europe - Autumn 2026 available on 12 October
What the studio does
Journalism
Reporting on health and life sciences in Europe for Rapporteur (Euractiv), EU Perspectives, European Biotechnology Magazine and APM Market Access.
Editorial work
Commissioned writing and editing for organisations in health and life sciences. Interviews, features, reports, and the editing that makes them shine.
Creative editorial formats
Latest reporting
EU must open investigation against Washington for ‘unlawful coercion’, says Belgian health minister
RAPPORTEUR (EURACTIV) - The EU must open an investigation against Washington for "unlawful coercion in national matters", Belgian Deputy Prime Minister and Health Minister Frank Vandenbroucke said on Tuesday, 6 October. Read more
EURACTIV - A decade after the first biosimilar reached European patients with rheumatoid arthritis, the evidence is in: patients do as well on the copies as on the original biologics, and a million patient-years of use confirm they are safe. Read more
EU PERSPECTIVES - A weight-loss jab bought through a social media advert can contain the wrong drug, the wrong dose, or no active ingredient at all. Fake medicines now reach Europeans through the same feeds as holiday photos. Every advert earns the platform money, and the tools to stop it already sit in EU law. Read more











